Various Circulatory System Anticoagulation
Conditions
Interventions
Anticoagulation control and monitoring with versus without laboratory-provided computerized decision support (CDS)
Sponsors
Ontario Program for Optimal Therapeutics (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Physicians: 1. Family or general practitioner 2. Full-time office practice 3. Practice address within study laboratory catchment area 4. At least 3 eligible patients willing to participate Patients: 1. On long-term warfarin therapy 2. Using the study laboratory for international normalized ratio (INR) tests and expecting to continue to do so for at least 12 months
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Acceptability of the CDS service, as assessed by the proportion of physicians who would continue to use it if offered 2. Estimated effectiveness, as assessed by percentage of time within target INR range | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemorrhagic and thromboembolic events requiring hospital attendance | — |
Countries
Canada
Outcome results
None listed